You have 9 free searches left this month | for more free features.

City

Condition

Fatty Liver, Nonalcoholic (1)

Hepatic Impairment (1)

NAFLD (1)

Non-alcoholic Fatty Liver Disease (1)

Non-alcoholic Steatohepatitis (1)

Nonalcoholic Fatty Liver Disease (1)

Nonalcoholic Steatohepatitis (1)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Merck Sharp & Dohme LLC (2)

Collaborator

Intervention

efinopegdutide (2)

placebo (1)

semaglutide (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

efinopegdutide

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Non-alcoholic Steatohepatitis, Hepatic Impairment Trial (Efinopegdutide)

Not yet recruiting

Non-alcoholic Steatohepatitis
Hepatic Impairment

Efinopegdutide

(no location specified)

Sep 18, 2023

Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial (Efinopegdutide, Semaglutide, Placebo)

Not yet recruiting

Non-alcoholic Fatty Liver Disease
+4 more

Efinopegdutide
+2 more

(no location specified)

May 17, 2023